Page 11 - ARNM-2-1
P. 11

Advances in Radiotherapy
            & Nuclear Medicine                                                 Pediatric myelosuppression in radiotherapy



            between gender- and radiation-induced myelosuppression   after propensity score matching is presented in  Table 6.
            (odds ratio [OR]  = 1.75; 95% confidence interval   The results revealed that gender was not associated with
            [CI]: 0.52 – 5.87; P > 0.05).                      post-radiotherapy myelosuppression (OR = 1.47, 95%
                                                               CI: 0.19 – 12.40, P > 0.05).
            3.2.2. Subgrouping according to age
                                                                 Next, patients were stratified based on an age cutoff of
            The patients were divided according to age, using a cutoff   10 years, and the differences in gender, prescribed dose,
            of 10. No differences were observed between the two age   treatment fraction, and treatment duration between the
            subgroups in terms of the location of radiotherapy in   two groups were depicted using median and quartile ranges
            the study, as depicted in Table 3. As shown in Table 4, no   due to the different sample sizes. After propensity score
            significant association was observed between age-  and   matching, 14 patients aged ≤10 years and 14 patients aged
            radiation-induced myelosuppression (OR = 1.40, 95%   >10 years were included in the study. The differences in
            CI: 0.42 – 4.26, P > 0.05).                        gender, prescribed dose, treatment fraction, and treatment

            3.2.3. Subgrouping analysis                        duration between the two groups were not statistically
                                                               significant (P > 0.05). Detailed information is provided in
            To determine the radiation dose, the patients were divided   Table 7. A case–control study of the relationship between
            into two groups using propensity score matching.   age and myelosuppression after radiotherapy is presented
              First, the two groups were divided according to their   in  Table 8, revealing no association between age and
            gender. After propensity score matching, ten male and ten   post-radiotherapy myelosuppression after grouping by age
            female patients were included, and the differences in age,   (OR = 0.76, 95% CI: 0.13 – 4.20, P > 0.05).
            prescribed dose, treatment fraction, and treatment duration
            between the two groups were not statistically significant   4. Discussion
            (P > 0.05). Detailed information is presented in Table 5.   Radiation-induced  injury  to normal tissues and  organs
            The  relationship  between  gender  and  myelosuppression   is a key challenge in radiotherapy. Due to growth and
                                                               development, the consequences and long-term risks of
            Table 2. Relationship between sex and bone marrow   radiological injury are more severe in children than in
                                                                    13
            suppression after radiotherapy                     adults.  As a result, there is a consensus among scholars to
                                                               make special considerations for pediatric patients during
                                Myelosuppression after radiotherapy  treatment plan optimization that is different from those for
                                 Yes                  No       adults. However, the specific implementation strategies for
            Male                  21                  12       different organs require further study.
            Female                8                    8
                                                                 The work by Pearce et al.  demonstrated that exposure
                                                                                     14
                                                               to ionizing agents during computed tomography (CT)
            Table 3. Location of radiotherapy in two age subgroups  scanning significantly increased the risk of leukemia in
                                                               pediatric patients by affecting the red bone marrow. As
            Radiotherapy regions      Age≤10        Age>10     the radiotherapy dose is much higher than the imaging
            Head and neck               18            21       dose, exposure to radiotherapy in the red bone marrow
            Chest and abdomen            1             5       of pediatric patients increases the risk of uncertain
            Foot                         0             1       effects, such as secondary carcinogenicity. Radiotherapy
            Femur                        0             1       also directly increases the risk of side effects such as
            Tibia                        0             1       myelosuppression, which is clinically manifested by
            Fibula                       0             1       significant changes in routine blood parameters and is one
            Upper limbs                  0             1       of the major risks during radiotherapy in pediatric patients.
                                                               The present study revealed that, compared to the reported
                                                               incidence of radiation-induced myelosuppression of more
            Table 4. Relationship between age and bone marrow   than grade II in approximately 32% of adult patients in the
            suppression after radiotherapy                     head and neck regions, the incidence in pediatric patients

            Age                  Myelosuppression after radiotherapy  was 59.18%, approximately double that of adults. Another
                                  Yes                 No       study on radiation-induced myelosuppression of more
                                                               than grade III in adults and children observed a similar
            ≤10 years             11                   9       phenomenon: the percentage of leukopenia of more than
            >10 years             18                  11       grade III was 32%, which was higher than that of 3% in the


            Volume 2 Issue 1 (2024)                         3                       https://doi.org/10.36922/arnm.2519
   6   7   8   9   10   11   12   13   14   15   16